Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin (GSK2857916)

NCT04549363 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT04549363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04549363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin (GSK2857916)
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Terminated
Start date
December 21, 2020
Completion date
November 21, 2022
Enrollment
16 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma